Daryl Gaugler

CIK 1928278 · View on SEC EDGAR ↗

Insider

First SEC filing: May 11, 2022 · Latest: May 11, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 13 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

13 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 13, 2024 PCRX S 10b5-1 500 $19.76 $9,880 115,200 Direct -0.43% Disposed 21.9% (price as of 2026-08-20)
Sept. 13, 2024 PCRX S 10b5-1 500 $12.86 $6,430 115,700 Direct -0.43% Disposed 87.3% (price as of 2026-08-20)
June 13, 2024 PCRX S 10b5-1 1,000 $28.38 $28,380 116,040 Direct -0.85% Disposed -15.1% (price as of 2026-08-20)
June 7, 2023 PCRX S 10b5-1 1,047 $37.86 $39,639 21,539 Direct -4.64% Disposed -36.4% (price as of 2026-08-20)
June 6, 2023 PCRX S 10b5-1 1,005 $38.99 $39,185 22,586 Direct -4.26% Disposed -38.2% (price as of 2026-08-20)
June 5, 2023 PCRX S 10b5-1 1,000 $38.74 $38,740 23,591 Direct -4.07% Disposed -37.8% (price as of 2026-08-20)
May 31, 2023 PCRX S 10b5-1 2,500 $39.08 $97,700 24,591 Direct -9.23% Disposed -38.4% (price as of 2026-08-20)
June 6, 2022 PCRX S 1,106 $61.37 $67,875 11,494 Direct -8.78% Disposed -60.8% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 14, 2023 PCRX Stock Option (Right to Buy) Common Stock (25,000) $38.74 June 14, 2033 25,000 Acquired
May 31, 2023 PCRX Stock Option (Right to Buy) Common Stock (2,500) $34.00 June 4, 2023 2,500 Disposed
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (10,000) $59.39 June 8, 2032 10,000 Acquired
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (19,800) $59.39 June 8, 2032 19,800 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
May 11, 2022 PCRX Common Stock 12,600 Direct
May 11, 2022 PCRX Stock Option (Right to Buy)→ Common Stock (15,000) 15,000 Direct
May 11, 2022 PCRX Stock Option (Right to Buy)→ Common Stock (20,000) 20,000 Direct
May 11, 2022 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
May 11, 2022 PCRX Stock Option (Right to Buy)→ Common Stock (20,000) 20,000 Direct
May 11, 2022 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PCRX

President, Commercial Operations(10)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $501,673 $225,900 $387,400 $398,307 — — $20,347 $1,533,627
2022 $469,942 $287,900 $766,131 $746,490 — — $20,933 $2,291,396

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.